Frequently Asked Questions
The global venous stents market was valued at USD 0.87 Billion in 2022.
The venous stents market is expected to grow at a CAGR of 8.50% between 2023 and 2030, reaching USD 1.54 Billion in 2030.
Leg is the leading segment by material, holding over 43% share in terms of value in 2022.
The chronic deep vein thrombosis segment governs the demand for venous stents globally, holding a massive share of over 80% in 2022.
North America is fueling the growth of the venous stents industry, with an over one-third share in 2022.
The top players include Boston Scientific Corporation, Becton, Dickinson and Company, Gore Medical, Cook Medical, Optimed Medizinische Instrumente GmBH, Medtronic Plc, Medica Germany GMBH & Co. KG, Cordis Inc., and MicroPort Scientific Corporation
Investments made by major companies in the development of flexible venous stents with high radial strength and rising healthcare spending are the major market drivers.
The major market restraints include a lack of awareness of venous stents and the high cost of stenting.
The huge growth potential in Asia Pacific, increasing adoption from educational institutes, and new ways of distribution are the major opportunities in the venous stents industry.